Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems

Aydin, Hakan; USLU, Hakan; AKTAŞ, Osman

Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems

Osman AKTAŞ, (Atatürk Üniversitesi Tıp Fakültesi Tıbbi Mikrobiyoloji Anabilim Dalı, Erzurum, Türkiye)

Hakan AYDIN, (Atatürk Üniversitesi Veteriner Fakültesi Viroloji Anabilim Dalı, Erzurum, Türkiye)

Hakan USLU (Atatürk Üniversitesi Tıp Fakültesi Tıbbi Mikrobiyoloji Anabilim Dalı, Erzurum, Türkiye)

Turkish Journal of Medical Sciences

2 0

Yıl: 2016 Cilt: 46 Sayı: 2 Sayfa Aralığı: 368 - 373 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems

Öz:

Background/aim: Human parvovirus B19 is a pathogen that affects different parts of the body. We planned this study because of the lack of data on B19 seroprevalence based on different body-system diseases. Materials and methods: The prevalence of parvovirus B19 antibodies was investigated retrospectively in 1239 patients by review of medical records from 2009 2012, according to their diseases classified under general titles in compliance with the International Classification of Diseases (ICD-10). Parvovirus B19-specific antibodies were detected by quantitative enzyme immunoassays. Results: The positivity rate was 27.8% for only IgG, 8.5% for only IgM, and 2.6% for both IgG and IgM. The highest positivity for IgG alone was found in musculoskeletal system and connective tissue diseases (55.9%), while the highest positivity for IgM was found in neoplasms (16.4%). The highest positivity for IgG was seen in rheumatoid arthritis (72.2%) and pregnancy (52.6%), and the highest positivity for total IgM was found in upper respiratory tract disease (21.0%) and hepatic failure (17.1%). Conclusions: Parvovirus B19 seroprevalence was relatively low in northeastern Anatolia compared to most serological studies conducted in other regions. We think that this study has provided the first wide-ranging information on the seroprevalence of B19 in diseases and disorders of the major human body systems.

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Koppelman MH, Cuijpers HT, Wessberg S, Valkeajärvi A, Pichl L, Schottstedt V, Saldanha J. Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA. Transfusion 2012; 52: 14981508.
2. Schenk T, Enders M, Pollak S, Hahn R, Huzly D. High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol 2009; 47: 106110.
3. Douvoyianni M, Litman N, Goldman DL. Neurologic manifestations associated with parvovirus B19 infection. Clin Infect Dis 2009; 48: 17131723.
4. Florea AV, Ionescu DN, Melhem MF. Parvovirus B19 infection in the immunocompromised host. Arch Pathol Lab Med 2007; 131: 799804.
5. Lamont RF, Sobel JD, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Kim SK, Uldbjerg N, Romero R. Parvovirus B19 infection in human pregnancy. BJOG 2011; 118: 17586.
6. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15: 485505.
7. Melegaro A, Jit M, Zagheni E, Edmunds WJ. What types of contacts are important for the spread of infections? Using contact survey data to explore European mixing patterns. Epidemics 2011; 3: 143151.
8. Kavita ND, Brustman, Lois EB. Parvovirus in pregnancy. Postgrad Obstet Gynecol 2014; 34: 15.
9. Steindel SJ. International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets. J Am Med Inform Assoc 2010; 17: 274282.
10. Kara M, Balcı M, Yapça ÖE, Yılmaz N. Parvovirus B19 infection during pregnancy: clinical course and prognosis. JOPP Derg 2013; 5: 16 (in Turkish with abstract in English).
11. Çolak D, Öğünç D, Aktekin M, Başustaoğlu AH, Gültekin M. Antalyanın Ahatlı Bölgesinde 4-6 yaş grubu çocuklarda Parvovirus B19 antikor prevalansı. Klimik Derg 1998; 11: 61 62 (in Turkish).
12. Işık N, Sabahoğlu E, Işık DM, Anak S, Ağaçfidan A, Bozkaya E. Follow up of patients pre-diagnosed as parvovirus B19 infection. Türk Mikrobiyol Cem Derg 2004; 34: 6266 (in Turkish with abstract in English).
13. Türk Dağı H, Özdemir M, Baykan M, Baysal B. Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia region, Turkey. Mikrobiyol Bul 2010; 44: 467472 (in Turkish with abstract in English).
14. Röhrer C, Gärtner B, Sauerbrei A, Böhm S, Hottenträger B, Raab U, Thierfelder W, Wutzler P, Modrow S. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 2008; 136: 15641575.
15. Kishore J, Srivastava M, Choudhary N. Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors. Asian J Transfus Sci 2010; 4: 8690.
16. Su WJ, Ni YH, Liu DP, Chiou LS, Cheng WY, Wu JS, Lu CY. Low seroprevalence of parvovirus B19 in Taiwanese children and young adults. Pediatr Neonatol 2010; 51: 265268.
17. Ziyaeyan M, Pourabbas B, Alborzi A, Mardaneh J. Prevalence of antibody to human parvovirus B19 in pre-school age/young adult individuals in Shiraz, Iran. Pak J Biol Sci 2007; 10: 1763 1765.
18. Weissbrich B, Süss-Fröhlich Y, Girschick HJ. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis. Arthritis Res Ther 2007; 9: R82.
19. Us T, Çetin E, Kaşıfoğlu N, Akgün Y, Bal C. Investigation of the etiologic role of parvovirus B19 by immunologic and molecular methods in rheumatoid arthritis and systemic lupus erythematosus. Turkiye Klinikleri J Med Sci 2013; 33: 334338.
20. Türk Dağı H, Özdemir M, Doğan M, Tüfekçi O, Küçüksaraç S, Baysal B. Investigation of parvovirus B19 antibodies in patients with rheumatoid arthritis. Selçuk Tıp Derg 2012; 28: 68 (in Turkish with abstract in English).
21. Regaya F, Oussaief L, Bejaoui M, Karoui M, Zili M, Khelifa R. Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia. BMC Infect Dis 2007; 7: 123.
22. Iwalokun BA, Iwalokun SO, Hodonu SO. Seroprevalence of parvovirus B19 antibodies and evidence of viremia among Nigerian patients with sickle cell anemia. J Biomed Res 2013; 27: 272282.
23. Wildig J, Cossart Y, Peshu N, Gicheru N, Tuju J, Williams TN, Newton CR. Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control study. BMC Infect Dis 2010; 10: 88.
24. Ghazi HO. Prevalence of antibodies to human parvovirus B19 in Saudi women of childbearing age in Makkah. J Fam Community Med 2007; 14: 1517.
25. Jensen IP, Thorsen P, Jeune B, Møller BR, Vestergaard BF. An epidemic of parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors. BJOG 2000; 107: 637643.
26. Kishore J, Sen M, Kumar A, Kumar A. A pilot study on parvovirus B19 infection in paediatric haematological malignancies. Indian J Med Res 2011; 133: 407413.

APA	AKTAŞ O, Aydin H, USLU H (2016). Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems. , 368 - 373.
Chicago	AKTAŞ Osman,Aydin Hakan,USLU Hakan Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems. (2016): 368 - 373.
MLA	AKTAŞ Osman,Aydin Hakan,USLU Hakan Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems. , 2016, ss.368 - 373.
AMA	AKTAŞ O,Aydin H,USLU H Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems. . 2016; 368 - 373.
Vancouver	AKTAŞ O,Aydin H,USLU H Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems. . 2016; 368 - 373.
IEEE	AKTAŞ O,Aydin H,USLU H "Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems." , ss.368 - 373, 2016.
ISNAD	AKTAŞ, Osman vd. "Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems". (2016), 368-373.

APA	AKTAŞ O, Aydin H, USLU H (2016). Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems. Turkish Journal of Medical Sciences, 46(2), 368 - 373.
Chicago	AKTAŞ Osman,Aydin Hakan,USLU Hakan Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems. Turkish Journal of Medical Sciences 46, no.2 (2016): 368 - 373.
MLA	AKTAŞ Osman,Aydin Hakan,USLU Hakan Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems. Turkish Journal of Medical Sciences, vol.46, no.2, 2016, ss.368 - 373.
AMA	AKTAŞ O,Aydin H,USLU H Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems. Turkish Journal of Medical Sciences. 2016; 46(2): 368 - 373.
Vancouver	AKTAŞ O,Aydin H,USLU H Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems. Turkish Journal of Medical Sciences. 2016; 46(2): 368 - 373.
IEEE	AKTAŞ O,Aydin H,USLU H "Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems." Turkish Journal of Medical Sciences, 46, ss.368 - 373, 2016.
ISNAD	AKTAŞ, Osman vd. "Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems". Turkish Journal of Medical Sciences 46/2 (2016), 368-373.